Comparing smoking behavior between female-to-male and male-to-female transgender adults.
gender identity
smoking behaviour
transgender
Journal
Tobacco prevention & cessation
ISSN: 2459-3087
Titre abrégé: Tob Prev Cessat
Pays: Greece
ID NLM: 101693412
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
08
2019
revised:
18
11
2019
accepted:
22
11
2019
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
This study aimed to assess the association between current smoking and gender identity among transgender individuals. Data were collected using a cross-sectional survey distributed among transgender individuals attending the Houston Pride Festival and those seeking care at a local transgender health clinic. Relevant variables were compared between female-to-male (FTM) and male-to-female (MTF) transgender individuals using χ The study sample (N=132) comprised 72 MTF (54.5%) and 60 FTM (45.5%) transgender individuals. Mean age of participants was 31.8 years. The sample was racially and ethnically diverse: 45.8% Caucasian, 25.2% Hispanic/Latino, 16.8% African American, and 12.2% other. Current smoking prevalence was 26.7% and 13.9% among FTM and MTF individuals, respectively. Transgender individuals were more likely to self-report current smoking if they were FTM (OR=3.76; 95% CI: 1.17-12.06; p=0.026) or were insured (OR=4.49; 95% CI: 1.53-13.18; p=0.006). This study reports on important findings by examining intragroup differences in smoking behavior among the transgender population. However, further research is needed for tailoring smoking prevention and cessation interventions for transgender subgroups.
Identifiants
pubmed: 32548339
doi: 10.18332/tpc/114513
pii: 2
pmc: PMC7291890
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 Tamí-Maury I.
Déclaration de conflit d'intérêts
The authors have each completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. J. Blalock reports grants from Cancer Prevention & Research Institute of Texas, University of Texas MD Anderson Cancer Center Lung Moon Shot and National Institutes of Health, and grants from Arnold Foundation, outside the submitted work.
Références
Tob Use Insights. 2019 May 23;12:1179173X19849419
pubmed: 31205426
MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8
pubmed: 19008791
J Community Health. 2017 Oct;42(5):903-910
pubmed: 28321648
CA Cancer J Clin. 2015 Sep-Oct;65(5):384-400
pubmed: 26186412
Am J Prev Med. 2017 Jul;53(1):e1-e7
pubmed: 28094133
Nicotine Tob Res. 2016 Jun;18(6):1502-8
pubmed: 26438646
Soc Sci Med. 2007 Jun;64(11):2201-9
pubmed: 17383784
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
LGBT Health. 2019 Jul;6(5):235-241
pubmed: 31140928
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005597
pubmed: 30950651
Res Nurs Health. 2014 Oct;37(5):391-8
pubmed: 25155799
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Nicotine Tob Res. 2007 Jan;9 Suppl 1:S65-71
pubmed: 17365728
J Gen Intern Med. 2016 Oct;31(10):1198-205
pubmed: 27329121
Nurs Clin North Am. 2012 Mar;47(1):55-70
pubmed: 22289398
Nicotine Tob Res. 2017 Jan;19(1):3-13
pubmed: 27199385
J Consult Clin Psychol. 2011 Apr;79(2):142-52
pubmed: 21443320
Prev Med. 2019 Jun;123:143-151
pubmed: 30902700
Am J Health Promot. 2018 Jun;32(5):1178-1186
pubmed: 28318307
Contemp Clin Trials. 2017 Mar;54:77-83
pubmed: 28088514
Obstet Gynecol. 2019 Nov;134(5):959-963
pubmed: 31599839
Curr Opin Psychol. 2015 Oct 1;5:72-77
pubmed: 26075291
LGBT Health. 2018 Oct;5(7):401-411
pubmed: 30334686
Lancet. 2016 Jul 23;388(10042):390-400
pubmed: 27323925